학술논문
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON–SEOM registry
Document Type
Article
Author
Arias-Martinez, A.; Martínez de Castro, E.; Gallego, J.; Arrazubi, V.; Custodio, A.; Fernández Montes, A.; Diez, M.; Hernandez, R.; Limón, M.L.; Cano, J.M.; Vidal-Tocino, R.; Macias, I.; Visa, L.; Martin Richard, M.; Sauri, T.; Hierro, C.; Gil, M.; Cerda, P.; Martínez Moreno, E.; Martínez Lago, N.; Mérida-García, A.J.; Gómez González, L.; García Navalón, F.J.; Ruiz Martín, M.; Marín, G.; López-López, F.; Ruperez Blanco, A.B.; Fernández, A.F.; Jimenez-Fonseca, P.; Carmona-Bayonas, A.; Alvarez-Manceñido, F.
Source
In: Clinical and Translational Oncology . (Clinical and Translational Oncology, 2024)
Subject
Language
English
ISSN
16993055
1699048X
1699048X